<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    wjns
   </journal-id>
   <journal-title-group>
    <journal-title>
     World Journal of Neuroscience
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2162-2000
   </issn>
   <issn publication-format="print">
    2162-2019
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/wjns.2025.151002
   </article-id>
   <article-id pub-id-type="publisher-id">
    wjns-138425
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Biomedical 
     </subject>
     <subject>
       Life Sciences
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Toxocara canis Myelitis, about a Case in the Neurology Department of the Ignace Deen University Hospital of Conakry
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Namory
      </surname>
      <given-names>
       Camara
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Mohamed Lamine
      </surname>
      <given-names>
       Touré
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Kaba
      </surname>
      <given-names>
       Condé
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Mohamed Lamine
      </surname>
      <given-names>
       Condé
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Malé
      </surname>
      <given-names>
       Doré
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Karinka
      </surname>
      <given-names>
       Diawara
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Mohamed
      </surname>
      <given-names>
       Traoré
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Fodé Abass
      </surname>
      <given-names>
       Cissé
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aDepartment of Neurology, Conakry University Hospital, Conakry, Guinea
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aSimbaya Institute of Neurology, Conakry, Guinea
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     23
    </day> 
    <month>
     12
    </month>
    <year>
     2024
    </year>
   </pub-date> 
   <volume>
    15
   </volume> 
   <issue>
    01
   </issue>
   <fpage>
    8
   </fpage>
   <lpage>
    12
   </lpage>
   <history>
    <date date-type="received">
     <day>
      6,
     </day>
     <month>
      October
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="published">
     <day>
      22,
     </day>
     <month>
      October
     </month>
     <year>
      2024
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      22,
     </day>
     <month>
      December
     </month>
     <year>
      2024
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    Toxocariasis is a helminthic zoonosis due to the presence in the human body of larvae of Toxocara sp., roundworms of the Ascaridae family. Less than 50 cases of central involvement related to toxocarasis have been reported in immunocompetent individuals. This involvement can result in epilepsy, meningoencephalitis, myelitis or encephalopathy. The standard treatment is albendazole at a dosage of 10 to 15 mg/kg/day. The duration of treatment varies greatly depending on the clinical cases reported, ranging from 5 days to several weeks in the case of severe forms. We report a case of myelitis due to Toxocara canis in a 14-year-old patient admitted for gait disorders. The laboratory assessment shows isolated hypereosinophilia at 8000 elements per mm
    <sup>3</sup>. Medullary magnetic resonance imaging (MRI) showed an intradural process of inflammatory and infectious appearance extended between T10 and L1 levels, hypointense in T1, hyperintense in T2, and homogeneous. Parasitological analysis of the stools noted the presence of high concentrations of Toxocara canis. Serology by ELISA (enzyme-linked immunosorbent assay) is strongly positive for toxocariasis, and western blot confirms the presence of antibodies directed against Toxocara larvae. Treatment with albendazole 400 mg × 2/day for 10 days associated with corticosteroid therapy (prednisone 50 mg/day for 5 days) allowed the disappearance of pain in 8 days, normalization of eosinophilia and improvement of walking.
   </abstract>
   <kwd-group> 
    <kwd>
     Myelitis
    </kwd> 
    <kwd>
      Toxocara canis
    </kwd> 
    <kwd>
      Conakry
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>Toxocarasis is a helminthic zoonosis caused by the presence in the human body of larvae of Toxocara sp., roundworms of the Ascaridae family. To date, only two species, Toxocara canis and Toxocara cati, have been recognized as causative agents of the human disease. Adults of both species are parasites of the digestive tract of their respective definitive hosts, canids and felids. In the past, T. canis was considered the sole cause of human toxocariasis. Although this role is undeniable, there is now substantial evidence that T. cati larvae can also parasitize humans, causing a disease with a clinical-biological spectrum similar to that caused by T. canis larvae <xref ref-type="bibr" rid="scirp.138425-1">
     [1]
    </xref>. Central neurological involvement is rare during parasitoses and is therefore little known <xref ref-type="bibr" rid="scirp.138425-2">
     [2]
    </xref>. Neurological toxocariasis (NT) is an even more severe form of the disease. Although rare, it occurs when Toxocara larvae attach themselves to the central or peripheral nervous system. The patient presents with nonspecific symptoms such as fever, headache, and seizures. Depending on the area affected, the infection can cause various serious neurological manifestations, such as meningoencephalitis, or other neurological manifestations, such as eosinophilic meningomyelitis, cerebral vasculitis, epilepsy, myelitis, radiculitis, cranial nerve involvement, or skeletal muscle disease. This form is uncommon <xref ref-type="bibr" rid="scirp.138425-3">
     [3]
    </xref>.</p>
   <p>After obtaining the informed consent of the parents, we report a case of Toxocara canis myelitis in a 14-year-old patient admitted for gait disturbances.</p>
  </sec><sec id="s2">
   <title>2. Observation</title>
   <p>Our patient is a 14-year-old boy who presented with recent gait disorders. A few days earlier, he had lower back pain radiating to the lower limbs, which gradually developed in a context of fever. No particular known history. The interview found no infectious contagion or recent travel abroad. His clinical examination found a limp when walking, a scoliosis posture with tension in the paravertebral muscles, lively osteotendinous reflexes in the lower limbs, and a decrease in segmental muscle strength rated at 3/5 proportional to the lower limbs. The biological assessment shows a hypeleucocytosis with neutrophil polymorphonuclear predominance at 8000 cells/mm<sup>3</sup>. Renal function, liver function tests, CRP and blood sugar are normal. The immunological assessment (antinuclear antibodies, anti-native DNA antibodies, ANCA) and serum protein electrophoresis were within normal limits. There was pleocytosis of the CSF with eosinophilia. Medullary magnetic resonance imaging (MRI) showed an intramedullary process of inflammatory appearance extending between levels T11 and L1, measuring 14 cm in height and 3 cm in thickness, hypointense in T1, hyperintense in T2, and homogeneous. Parasitological analysis of the stools noted the presence of high concentrations of Toxocara canis. Serology by the ELISA technique (enzyme-linked immunosorbent assay) is strongly positive for toxocariasis, and the western blot confirms the presence of antibodies directed against Toxocara larvae. The presence of hypereosinophilia, positive Toxocara serology, antibodies directed against Toxocara larvae, and the spinal cord MRI appearance allow us to retain the diagnosis of spinal cord toxocariasis.</p>
   <p>Treatment with albendazole 400 mg × 2/day for 10 days associated with corticosteroid therapy (prednisone 50 mg/day for 5 days) allowed the disappearance of pain in 8 days, the normalization of eosinophilia and the improvement of walking. This is a patient for whom the follow-up continued monthly and for 6 months with a clinical reassessment once a month and under albendazole at 400 mg per day where we noted a perfect recovery without sequelae or pain.</p>
  </sec><sec id="s3">
   <title>3. Discussion</title>
   <p>Less than 50 cases of central involvement related to toxocariasis have been reported in immunocompetent individuals. There is involvement by the larvae of the central or peripheral nervous system. Depending on the area affected, this can cause various serious neurological manifestations, for example meningoencephalitis or myelitis <xref ref-type="bibr" rid="scirp.138425-3">
     [3]
    </xref>-<xref ref-type="bibr" rid="scirp.138425-5">
     [5]
    </xref>. Our patient was immunocompetent with myelitis with spastic paraparesis.</p>
   <p>Toxocariasis is classically responsible for visceral Larva Migrans syndrome; neurological involvement is exceptional. CSF hypereosinophilia, often transient, is an element of orientation but can be observed in other parasitic diseases, including bilharzia. MRI can show white matter (WM) lesions, in T2 hypersignal. These abnormalities, generally persistent, seem to be related to ischemic lesions secondary to vasculitis <xref ref-type="bibr" rid="scirp.138425-3">
     [3]
    </xref>-<xref ref-type="bibr" rid="scirp.138425-6">
     [6]
    </xref>.</p>
   <p>The clinical picture of our patient suggests myelitis secondary to Toxocara canis infection, revealed by a gait disorder. The arguments in favor of this diagnosis are:</p>
   <p>Diagnostic certainty is based on the demonstration of specific IgE by Elisa, an examination also positive in our patient, or by a western blot also positive in our patient <xref ref-type="bibr" rid="scirp.138425-7">
     [7]
    </xref>.</p>
   <p>Antihelminthic treatment should be considered in the event of persistent hypereosinophilia or clinical disorders <xref ref-type="bibr" rid="scirp.138425-4">
     [4]
    </xref>. The reference treatment is albendazole at a dosage of 10 to 15 mg/kg/day. The duration of treatment varies greatly depending on the clinical cases reported, ranging from 5 days to several weeks in the case of severe forms, an optimal duration of treatment has not been determined <xref ref-type="bibr" rid="scirp.138425-3">
     [3]
    </xref> <xref ref-type="bibr" rid="scirp.138425-8">
     [8]
    </xref>. The indication for corticosteroid therapy is formal and must precede antihelminthic treatment to limit clinical worsening linked to parasite lysis in ocular and neurological forms (1.5 mg/kg/day for 4 to 6 weeks) <xref ref-type="bibr" rid="scirp.138425-5">
     [5]
    </xref>. Its prognosis is usually good <xref ref-type="bibr" rid="scirp.138425-9">
     [9]
    </xref>. In our patient, treatment with albendazole 400 mg × 2/day for 10 days associated with corticosteroid therapy (prednisone 50 mg/day for 5 days) allowed the pain to disappear in 8 days, the eosinophilia to normalize and the walking to improve and we continued albendazole for 4 weeks with a clear regression of symptoms. Prevention of toxocariasis involves following normal hygiene rules, treating pets (cats or dogs) and limiting their access to areas reserved for children and vegetable gardens <xref ref-type="bibr" rid="scirp.138425-7">
     [7]
    </xref>.</p>
  </sec><sec id="s4">
   <title>4. Conclusions</title>
   <p>Toxocariasis is a helminthic zoonosis due to the presence in the human body of larvae of Toxocara sp., roundworms of the Ascaridae family.</p>
   <p>Our patient is a 14-year-old boy admitted for recent onset of gait disorders, which gradually developed in a context of fever. His clinical examination found limping when walking, a scoliosis posture with tension in the paravertebral muscles, lively osteotendinous reflexes in the lower limbs, and a decrease in segmental muscle strength rated at 3/5 proportional to the lower limbs. The biological assessment showed isolated hypereosinophilia at 8000 elements per mm<sup>3</sup>. Medullary magnetic resonance imaging (MRI) showed an intradural process of inflammatory and infectious appearance extending between the T10 and L1 levels, hypointense in T1, hyperintense in T2, and homogeneous. Parasitological analysis of the stools noted the presence of high concentrations of Toxocara canis. Serology by ELISA (enzyme-linked immunosorbent assay) was strongly positive for toxocariasis, and the western blot confirmed the presence of antibodies directed against Toxocara larvae.</p>
   <p>Treatment with albendazole 400 mg × 2/day for 10 days combined with corticosteroid therapy (prednisone 50 mg/day for 5 days) resulted in the disappearance of pain in 8 days, normalization of eosinophilia and improvement in walking.</p>
  </sec><sec id="s5">
   <title>Declaration</title>
   <p>We hereby certify that we assign copyright to the publisher, that this work has not been published before, and is not under consideration for publication elsewhere.</p>
   <p>We certify that all authors have read and approved the final version together and that ethical aspects have been respected throughout this study.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.138425-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Magnavala, J.F., Fillauxc, J. and Fabreb, R. (2014) Biological Diagnosis of Human Toxocariasis. Revue Francophone des Laboratoires, 464, 61-69.
    </mixed-citation>
   </ref>
   <ref id="scirp.138425-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Jauréguiberry, S. and Caumes, E. (2016) When to Consider a Parasitic Cause of a Central Nervous System Infection? Réanimation, 25, 69-82. &gt;https://doi.org/10.1007/s13546-016-1197-4
    </mixed-citation>
   </ref>
   <ref id="scirp.138425-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Beal, C., Milesi, A.M., Glace, B., Moisset, X., Vitello, N., Clavelou, P. and Hermet, M. (2015) Brain Damage from Toxocariasis. Revue Neurologique, 171, a136-a145.
    </mixed-citation>
   </ref>
   <ref id="scirp.138425-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Magnaval, J.F. (2006) Traitement des parasitoses cosmopolites. Médecine Tropicale, 66, 193-198.
    </mixed-citation>
   </ref>
   <ref id="scirp.138425-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Pelloux, H. and Faure, O. (2004) Toxocarose de l’adulte. La Revue de Médecine Interne, 25, 201-206. &gt;https://doi.org/10.1016/s0248-8663(03)00258-3
    </mixed-citation>
   </ref>
   <ref id="scirp.138425-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Jaulent, P., Pegat, A., Grosset-Janin, C., Durand-Dubief, F., Marignier, R. and Vukusic, S. (2017) Myelitis Migrans. Revue Neurologique, 173, S157. &gt;https://doi.org/10.1016/j.neurol.2017.01.293
    </mixed-citation>
   </ref>
   <ref id="scirp.138425-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Drault, J.N., Mehdaoui, H., Charet, E., Smadja, D., Chesneau, P., Tixier, F., et al. (1998) Décompensation respiratoire aiguë au cours d’une myélite due à Toxocara canis à propos d’un cas. Réanimation Urgences, 7, 589-593. &gt;https://doi.org/10.1016/s1164-6756(99)80009-7
    </mixed-citation>
   </ref>
   <ref id="scirp.138425-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ranasuriya, G., Mian, A., Boujaoude, Z. and Tsigrelis, C. (2014) Pulmonary Toxocariasis: A Case Report and Literature Review. Infection, 42, 575-578. &gt;https://doi.org/10.1007/s15010-014-0587-3
    </mixed-citation>
   </ref>
   <ref id="scirp.138425-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Jorge, D., Strady, C., Guy, B., Deslée, G., Lebargy, F. and Dury, S. (2016) Opacités pulmonaires multiples révélant une toxocarose. Revue de Pneumologie Clinique, 72, 273-276. &gt;https://doi.org/10.1016/j.pneumo.2016.03.004
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>